Stem Cell Therapy for Chronic Fatigue Syndrome: A Promising Approach, 2024, Vinski

https://jws.rivierapublishing.id/index.php/jws/article/view/1231

Stem Cell Therapy for Chronic Fatigue Syndrome: A Promising Approach
Authors

• Deby Susanti Pada Vinski Pada Vinski
• Svetlana TrofimovaInstitute of Bioregulation and Gerontology, St. Petersburg
• Jaime Rodriguez QuintosaEfhre International University, Barcelona
• Andi Kurniawan NugrohoUniversitas Semarang, Semarang
• CA SchroeterKastanienh of Clinic, Köln Junkersdorf
• Stevan JovanovicInstitut Médical de Champel, Geneva

DOI:
https://doi.org/10.58344/jws.v3i11.1231
Keywords:
chronic fatigue syndrome, immunomodulation, mesenchymal stem cells, regenerative medicine, stem cell therapy

Abstract

Chronic Fatigue Syndrome (CFS), or Myalgic Encephalomyelitis (ME), is a debilitating condition marked by persistent fatigue, cognitive dysfunction, and chronic pain, severely affecting quality of life.

This study explores the potential of mesenchymal stem cell (MSC) therapy as an innovative treatment for CFS.

Using a qualitative descriptive design and case studies, data were gathered through interviews, medical record reviews, and observations of patients undergoing MSC therapy.

The findings revealed significant improvements in fatigue, cognitive function, and physical well-being, with participants reporting better memory, concentration, reduced pain, and improved daily functioning.

While some sleep disturbances persisted, their severity was reduced.

These results highlight the potential of MSC therapy to alleviate CFS symptoms and enhance quality of life.

Despite its promise, challenges such as high costs, regulatory hurdles, and the need for standardized protocols persist.

Further research is required to confirm long-term efficacy and safety, contributing to the growing evidence for regenerative medicine in treating chronic conditions like CFS.

 

From the wiki: "There is also growing concern about the marketing and application of unapproved MSCs and mesenchymal stem cells that lack rigorous data to back up these clinical uses into patients by for-profit clinics.[70][71]"

I wonder if "promising" is closely related to political promises (ie. not worth much).